Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Hikma Farmaceutica, (Portugal) S.A.
FDA Inspection
•Hikma Farmaceutica, (Portugal) S.A.•April 21, 2023

Hikma Farmaceutica, (Portugal) S.A. – FDA Inspection, Apr 21, 2023

Record Details

This FDA Inspection record concerns Hikma Farmaceutica, (Portugal) S.A., with an inspection on April 21, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Hikma Farmaceutica, (Portugal) S.A.
Inspection Date
April 21, 2023
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Jose M. Cayuela (FDA Associated Person)
View Company Profile

ID · 953b74ba-98e1-45b9-9469-1a1f573c62c3

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1203129
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

14
  1. 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
  2. 21 CFR 211.160(b)(1)Incoming lots - conformance to written specs-
  3. 21 CFR 211.160(b)Scientifically sound laboratory controls
  4. 21 CFR 211.113(b)Procedures for sterile drug products
  5. 21 CFR 211.68(a)Written calibration / inspection records not kept
  6. 21 CFR 211.192Investigations of discrepancies, failures
  7. 21 CFR 211.166(a)Written program not followed
  8. 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
  9. 21 CFR 211.113(b)Procedures for sterile drug products
  10. 21 CFR 211.160(b)Scientifically sound laboratory controls

Showing 10 of 14 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Hikma Farmaceutica, (Portugal) S.A.

8
DateClassificationOfficeProject area
February 3, 2023VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
March 6, 2020VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
March 22, 2018NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
April 12, 2016VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
June 19, 2015VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 8 other inspections on the company page
Other documents for Hikma Farmaceutica, (Portugal) S.A.
  • FDA Inspection 1254066 - 2023-02-03
  • FDA Inspection 1125050 - 2020-03-06
  • FDA Inspection 1050480 - 2018-03-22
  • FDA Inspection 970483 - 2016-04-12
  • FDA Inspection 940389 - 2015-06-19

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hikma Farmaceutica, (Portugal) S.A.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.